Effect of Statins on the Risk of Different Stages of Prostate Cancer: A Meta-Analysis.

Li, Yun; Cheng, Xuan; Zhu, Jia-Lian; Luo, Wen-Wen; Xiang, Huai-Rong; Zhang, Qi-Zhi; Peng, Wen-Xing

Li, Yun; Cheng, Xuan; Zhu, Jia-Lian; Luo, Wen-Wen; Xiang, Huai-Rong; Zhang, Qi-Zhi; Peng, Wen-Xing.

Afiliación

Li Y; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Cheng X; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Zhu JL; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Luo WW; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Xiang HR; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Zhang QZ; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Peng WX; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.

Urol Int ; 106(9): 869-877, 2022.

Article en En | MEDLINE | ID: mdl-34518476

Asunto(s)

Inhibidores de Hidroximetilglutaril-CoA Reductasas; Neoplasias de la Próstata; Humanos; Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos; Incidencia; Masculino; Próstata; Neoplasias de la Próstata/epidemiología; Neoplasias de la Próstata/prevención & control; Riesgo

Palabras clave

Advanced prostate cancer; High-grade prostate cancer; Meta-analysis; Statins

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Male Idioma: En Revista: Urol Int Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google